Prevnar 20 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,431
Award facts
- Contract value 100% obligated
- $14,430.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,430.70 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Prevnar 20 vaccine in 0.5 mL syringe configuration. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical vendor within the federal pharmaceutical supply chain, serving military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a wholly-owned subsidiary of Cencora, Inc., the company leverages its established relationships with DLA and other federal agencies to fulfill essential medical supply requirements on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F5QZX?
SPE2DR26F5QZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F5QZX worth?
The government has obligated $14,431 on SPE2DR26F5QZX.
Is contract SPE2DR26F5QZX an order under another contract?
Yes. SPE2DR26F5QZX is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QZX competed?
The extent of competition for SPE2DR26F5QZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award